JESSICA JORDAN: Open Payments
NPI 1952931735 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,975 in 159 payments from 31 companies in 2025. Trend: 2023 $2,487 · 2024 $2,889 · 2025 $2,975
Food & beverage: $2,975
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $670 |
| UCB, Inc. | 10 | $288 |
| Amgen Inc. | 27 | $239 |
| ANI Pharmaceuticals, Inc. | 7 | $189 |
| Mallinckrodt Hospital Products Inc. | 8 | $187 |
| Novartis Pharmaceuticals Corporation | 11 | $175 |
| Indivior Inc. | 7 | $165 |
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| Janssen Biotech, Inc. | 8 | $142 |
| GlaxoSmithKline, LLC. | 8 | $138 |
Products named: RINVOQ, Bimzelx, PURIFIED CORTROPHIN GEL, ACTHAR, COSENTYX, SUBLOCADE, KRYSTEXXA, TREMFYA.
Industry payments across AL — which companies pay providers there.
